PYC-38

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePYC-38
Drug Alias Namephylomer (Phylogica)PYC-38
ClassificationBiologics > Protein drugs > Recombinant polypeptideNatural product/Extract
Mechanisms of ActionTranscription factor AP1 inhibitors
TargetsTranscription factor AP1
Therapy Area/IndicationsStrokeBrain Injuries, TraumaticRespiratory Distress Syndrome, Adult +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPYC Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPYC Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsStrokeBrain Injuries, TraumaticRespiratory Distress Syndrome, Adult +[4] 

Other Information

ATC CodeN/A
Related LinksN/A